Significant decrease of IgE antibodies after a three-year controlled study of specific immunotherapy to pollen allergens in children with allergic asthma

European Review for Medical and Pharmacological Sciences

Volumn 9, Issue 2, 2005, Pages 103-111

  Cantani, A ^a   Micera, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Allergic rhinitis; lgE and IgG antibodies; Pediatric asthma; Pediatric SIT; Very early onset

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E ANTIBODY; KETOTIFEN; NEDOCROMIL SODIUM; POLLEN ANTIGEN; STEROID;

ALLERGIC ASTHMA; ANTIBODY SPECIFICITY; ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOTHERAPY; ITALY; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; UNIVERSITY; URTICARIA; WHEEZING;

ALLERGENS; ANTIBODIES; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; POLLEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 19944394887     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Aas K. Hyposensitization in house dust allergy asthma. A double-blind controlled study with evaluation of the effect on bronchial sensitivity to house dust. Acta Paediatr Scand 1971; 60: 264-268.
2. Berg T, Nordvall L, Lanner Å. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation copared to a crude timothy pollen extract. I. Results of test in vivo. Int Arch Allergy Appl Immunol 1982; 63: 266-274.
3. Bertelsen A, Andersen JB, Christensen J, Ingemann L, Kristensen T, Ustergaard PA. Immunotherapy with dog and cat extracts in children. Allergy 1989; 44: 330-335.
4. Cantani A, Businco E, Benincori N, De Angelis M, Di Fazio A, Businco L. A three-year controlled study in children with pollinosis treated with immunotherapy. Ann Allergy 1984; 53: 79-84.
5. Cantani A, Businco E, Maglio A. Alternaria allergy: A three-year controlled study in children treated with immunotherapy. Allergol Immunopathol 1988; 16: 1-4.
6. Dreborg S, Agrell B, Foucard T, Kjellman NIM, Koivikko A, Nilsson S. A double blind multi-center immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical Results. Allergy 1986; 41: 131-140.
7. Kjellman N-IM, Lanner Å. Hyposensitization in childhood hay fever, a comparison of refined and timothy extracts. Allergy 1980; 35: 323-334.
8. Kuhn W, Urbanek R, Forster J, Dreborg S, Burow C. Hyposensibilizierung bei Pollinosis: dreijährige prospektive Vergleichsundersuchung bei Kindern. Allergologie 1985; 8: 103-109.
9. Möller C, Dreborg S. Cross reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy 1986; 16: 135-143.
10. Sundin B, Lilja G, Graff-Lonnevig V, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986; 77: 478-487.
11. Valovirta E, Koivikko A, Vanto T, et al. Immunotherapy in allergy to dog: a double-blind clinical study. Ann Allergy 1984; 53: 85-88.
12. Wahn U, Schweter C, Lind P, Løwenstein H. Prospective study on immunologic changes induced by two Dermatophagoides pteronyssimus extracts prepared from the whole mite culture and mite bodies. J Allergy Clin Immunol 1988; 82: 360-370.
13. Warner JO, Price JF, Soothill JF, Ney EN. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; ii: 912-915.
14. Cantani A, Arcese G, Lucenti P, Gagliesi D, Bartolucci M. A three year prospective study of allergen immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Invest Allergol Clin Immunol 1997; 7: 90-97.
15. Wasserman SI. Immunotherapy: how does it work? 50th AAAI Meeting, Chicago 12-17 March 1993. Syllabus p 24-28.
16. Varney VA, Hamid OA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. J Clin Invest 1993; 92: 644-651.
17. Jung CM, Prinz JC, Rieber EP, Ring J. A reduction in allergen-induced FceεII/CD23 expression on peripheral B cells correlates with successful hyposensitization in grass pollenosis. J Allergy Clin Immunol 1995; 95: 77-87.
18. Noon L. Prophylactic inoculation against hay fever. Lancet 1911: 1: 1572-1573.
19. Businco L, Zannino L, Cantani A, Corrias A, Fiocchi A, La Rosa M. Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective study. Pediatr Allergy Immunol 1995; 6: 44-47.
20. Cantani A, Gagliesi D. Specific immunotherapy in children. Allergy 1996; 51: 265-266.
21. Murray AB, Ferguson AC, Morrison BJ. Non-allergic bronchial hyperreactivity in asthmatic children increases with age and decreases with mite immunotherapy. Ann Allergy 1985; 54: 541-544.
22. Cocco G. Immunotherapy and natural history of respiratory allergic diseases. In Bonifazi F, Antonicelli L, eds. Allergen Immunotherapy. Up to date '90. Ancona: II Lavoro Editoriale Edizioni 1991; 26-30.
23. Creticos PS. Immunologic changes associated with immunotherapy. Immunol Allergy Clin North Am 1992; 12: 13-37.
24. Lichtenstein LM, Norman PS, Winkenwerden WL, Osler AG. In vitro studies of human ragweed allergy: Changes in cellular and humoral activity associated with specific desensitization. J Clin Invest 1966; 45: 1126-1136.
25. Platts-Mills TAE, van Maur RK, Ishizaka K, et al. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of istamine release. J Clin Invest 1967; 57: 1041-1050.
26. Levy DA, Osler AG. Studies on the mechanism of hypersensitivity phenomena. XVI. In vitro assay of reaginic activity in human sera: Effect of therapeutic immunization on seasonal titer changes. J Immunol 1967; 99: 1067-1077.
27. Tamir R, Castracane JM, Rocklin RE. Generation of suppres-sor cells in atopic patients during immunotherapy that modulate IgE synthesis. J Allergy Clin Immunol 1987; 79: 591-598.
28. Castracane JM, Rocklin RE. Detection of human auto-anti-idiotypic antibodies (Ab2). Isolation and characterization of Ab2 in the serum of a ragweed immunotherapy-treated patient. Int Archs Allergy Appl Immunol 1988; 86: 288-292.
29. Nish WA, Charlesworth EN, Davis TL, et al. The effect of immunotherapy on the cutaneous late phase response to antigen. J Allergy Clin Immunol 1994; 93: 484-493.
30. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children - a 14 year study. Pediatrics 1968; 42: 793-802.
31. Rak S, Björnson A, Håkanson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemiotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991; 88: 878-888.
32. Weeke B. Allergen specific immunotherapy. In Bonifazi F, Antonicelli L, eds. Allergen Immunotherapy. Up to date '90. Ancona: II Lavoro Editoriale Edizioni 1991; 39-48.
33. Pepys J. Skin testing. Br J Hosp Med 1975; 14: 412-417.
34. Dreborg S, Backman A, Basomba A, et al. Skin tests used in type I allergy testing. Position paper. Allergy 1989; 44 (Suppl 10): 1-59.
35. Aas K, Belin L. Suggestions for biologic qualitative testing and standardization of allergen extracts. Acta Allergol 1974; 29: 238-240.
36. Immunotherapy Subcommittee of the European Academy of Allergology and Clinical Immunology. Position Paper: Immunotherapy, eds Malling H-J, Weeke B. Allergy 1993; 48: (Suppl 14): 9-35.
37. Executive Committee, American Academy of Allergy and Clinical Immunology. The waiting period after allergen skin testing and immunotherapy. (Position statement). J Allergy Clin Immunol 1990; 85: 526-527.
38. Cantani A. The growing genetic links and the early onset of atopic diseases in children stress the unique role of the atopic march: a meta-analysis. J Invest Allergol Clin Immunol 1999; 9: 314-320.
39. Dreborg S. Features of immunotherapy in pediatrics. In Bonifazi F, Antonicelli L, eds. Allergen Immunotherapy. Up to date '90. Ancona: II Lavoro Editoriale Edizioni 1991; 94-104.
40. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 901-907.
41. Stevenson EC, Turner G, Heaney LG, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997; 27: 1027-1035.
42. Pohunck P, Roche WR, Turzikova J, Kudrmann J, Warner JO. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 1997; 19 (Suppl 25): 160A.
43. WHO Position Paper Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44): 1-42.
44. Passali D, Mösges R, Hassan HA, Bellussi L, The Working Group. International Conference on Allergic Rhinitis in Childhood. Allergy 1999; 54 (Suppl 55): 1-34.
45. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TAE. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92: 6-15.
46. La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999; 104: 425-432.
47. Purello d'Ambrosio F, Isola S, Ricciardi L, Levanti C, Musarra A. Efficacia e tollerabilità dell'immunoterapia sublinguale in bambini con asma da acari. Notiz Allergol 1993; 12: 259A.
48. Di Rienzo V, Puccinelli P, Frati F, Parmiani S. Grass pollen specific sublingual/swallow immunotherapy in children: open-controlled comparison among different treatment protocols. Allergol Immunopathol (Madr) 1999; 27: 145-151.
49. Möller C, Dreborg S, Lanner A, Bjorksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy A double blind study. Allergy 1986; 41: 271-279.
50. WHO Position Paper Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl 44): 1-42.
51. Passali D, Mösges R, Hassan HA, Bellussi L, The Working Group. International Conference on Allergic Rhinitis in Childhood. Allergy 1999; 54 (Suppl 55): 1-34.
52. Malling H-J, Løwenstein H. The 3rd Symposium on Specific Allergy '99 Copenhagen, Denmark April 15-17, 1999. Allergy 1999; 54 (Suppl 56): 1-10.
53. Marcucci F, Sensi L, Frati F, et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children mono-sensitized to mites. Allergy 2003; 58: 657-562.
54. Pajno GB, Vita D, Parmiani S, et al. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003; 33 :1641-1647.
55. Wüthrich B, Bucher Ch, Jorg W, et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Invest Allergol Clin Immunol 2003; 13: 145-148.
56. Ragusa FV, Passalacqua G, Gambardella R, et al. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience. J Invest Allergol Clin Immunol 1997; 7: 151-154.
57. Fu CL, Ye YL, Lee YL, Chiang BL. Both allergen-specific CD4 and CD8 Type 2 T cells decreased in asthmatic children with immunotherapy. Pediatr Allergy Immunol 2003 14: 284-291.
58. Moncayo Coello CV, Rosas Vargas MA, del Rio Navarro BE, et al. Quality of life in children with allergic rhinitis before and after being treated with specific immunotherapy (cases and controls). Rev Alerg Mex 2003; 50: 170-175.
59. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422.